Evidence map›Paper›PMID 42889541›Full record

ArticleIranian journal of basic medical sciences2026

Preparation, characterization, and comparison of the release of antibacterial peptide CM11 from PLGA nanoparticles and microparticles.

Mohammadmahdi Eshaghi, Mehrdad Moosazadeh Moghaddam, Marzieh Dehghani, Nematollah Jonaidi-Jafari, Hamid Hesarikia, Ramezan Ali Taheri

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Iranian journal of basic medical sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Mohammadmahdi EshaghiNanobiotechnology Research Center, New Health Technologies Institute, Baqiyatallah University of Medical Sciences, Tehran, Iran.
Mehrdad Moosazadeh MoghaddamTissue Engineering and Regenerative Medicine Research Center, New Health Technologies Institute, Baqiyatallah University of Medical Sciences, Tehran, Iran.
Marzieh DehghaniDepartment of Biophysics, College of Biological Sciences, Tarbiat Modares University, Tehran, Iran.
Nematollah Jonaidi-JafariHealth Management Research Center, Lifestyle and Spiritual Health Research Institute, Baqiyatallah University of Medical Sciences, Tehran, Iran.
Hamid HesarikiaTrauma Research Center, Clinical Sciences Institute, Baqiyatallah University of Medical Sciences, Tehran, Iran.
Ramezan Ali TaheriNanobiotechnology Research Center, New Health Technologies Institute, Baqiyatallah University of Medical Sciences, Tehran, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objectives: Materials and Methods: CM11-loaded PLGA nanoparticles (NPCM11) and microparticles (MPCM11) were prepared using a double-emulsion solvent evaporation (W1/O/W2) method and characterized for particle size, morphology, encapsulation efficiency, and Results: Optimum formulations of NPCM11 and MPCM11 were synthesized, exhibiting spherical morphology with average sizes of 281 nm and 7.63 µm, respectively. The encapsulation efficiency (EE%) of NPCM11 and MPCM11 was 63.5% and 60.3%, respectively, while the Conclusion: Overall, NPCM11 and MPCM11 were promising formulations of CM11 for treating

Indexed as

Antimicrobial peptideBiofilmsNanomedicinePolylactic acid-polyglycolic-acid copolymerPseudomonas aeruginosa

Identifiers

PMID42889541
PMCPMC13669728

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.